no doubt at all u are buying value all the way to $3.the shakeout of weak holders is over; instos will value the $40 mil annual royalties fr abbott/ centacor and the pipeline of projects in Domantis. centacor's remicade which uses ptd's patent is now a blockbuster drug with usd3 bill annual sales - ??? royalty $.
